We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

155 hedge funds and large institutions have $14.9M invested in Definium Therapeutics in 2022 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more call options, than puts

Call options by funds: $1.84M | Put options by funds: $842K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.4% less ownership

Funds ownership: 0.76% → 0.36% (-0.4%)

4% less first-time investments, than exits

New positions opened: 49 | Existing positions closed: 51

3% less funds holding

Funds holding: 159 → 155 (-4)

37% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 41

72% less capital invested

Capital invested by funds: $53.6M → $14.9M (-$38.6M)

Holders
155
Holders Change
-4
Holders Change %
-2.52%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
49
Increased
26
Reduced
41
Closed
51
Calls
$1.84M
Puts
$842K
Net Calls
+$1M
Net Calls Change
-$1.77M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$3.91M
2
E
Ergoteles
New York
+$917K
3
LPL Financial
LPL Financial
California
+$653K
4
Citadel Advisors
Citadel Advisors
Florida
+$457K
5
MFG
Merit Financial Group
Georgia
+$449K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$13.7M
2
State Street
State Street
Massachusetts
-$4.37M
3
Northern Trust
Northern Trust
Illinois
-$2.52M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.21M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$115K -$158K -12,517 -51%
HF
27
HRT Financial
New York
$111K +$136K +10,782 +1,336%
FC
28
Fore Capital
New York
$102K +$50.6K +4,000 +60%
YIH
29
Y-Intercept (HK)
Hong Kong
$94K +$124K +9,806 New
LCM
30
Laurion Capital Management
New York
$85K +$112K +8,822 New
IC
31
Ikarian Capital
Texas
$68K – – –
Bank of America
32
Bank of America
North Carolina
$68K +$49.4K +3,908 +124%
Parallax Volatility Advisers
33
Parallax Volatility Advisers
California
$64K +$177 +14 +0.2%
SC
34
Scotia Capital
Ontario, Canada
$58K +$6.54K +517 +9%
AGAM
35
Audent Global Asset Management
California
$50K – – –
GG
36
Gofen & Glossberg
Illinois
$46K – – –
Balyasny Asset Management
37
Balyasny Asset Management
Illinois
$42K +$55.9K +4,420 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$41K -$23.4K -1,848 -30%
ETC
39
Exchange Traded Concepts
Oklahoma
$38K +$38.8K +3,069 +339%
Creative Planning
40
Creative Planning
Kansas
$34K -$1.97K -156 -4%
Toronto Dominion Bank
41
Toronto Dominion Bank
Ontario, Canada
$30K +$848 +67 +2%
Legal & General Group
42
Legal & General Group
United Kingdom
$29K -$33.5K -2,644 -47%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$28K -$754K -59,573 -95%
QPW
44
Quantum Private Wealth
Florida
$28K +$38K +3,003 New
Squarepoint
45
Squarepoint
New York
$27K -$30.7K -2,430 -47%
AWM
46
Accurate Wealth Management
Florida
$26K +$4.99K +394 +17%
SAM
47
Shell Asset Management
Netherlands
$24K – – –
JIP
48
Jaffetilchin Investment Partners
Florida
$24K +$31.1K +2,457 New
Public Employees Retirement Association of Colorado
49
Public Employees Retirement Association of Colorado
Colorado
$23K +$23.8K +1,880 New
WS
50
Wedbush Securities
California
$23K +$30.4K +2,400 New
1
2
3 4 5

DFTX Hedge Fund Activity: Q2 2022 in Review

155 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2022, worth a combined $14.9M — down 72% from $53.6M a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of DFTX and 49 opened new positions — a net loss of 2 holders — while 41 trimmed existing stakes and 26 added.

The largest buyer was Millennium Management, adding an estimated $3.91M. The largest seller was BlackRock, cutting an estimated $13.7M.

  • 155 institutional investors held Definium Therapeutics (DFTX) as of Q2 2022, down from 159 in Q1 2022.
  • Funds reported $14.9M of Definium Therapeutics stock for Q2 2022, down 72% quarter-over-quarter.
  • 49 funds opened new Definium Therapeutics positions in Q2 2022 and 51 closed out, a net change of -2 holders.
  • The largest Definium Therapeutics buyer in Q2 2022 was Millennium Management, an estimated $3.91M added.
  • The largest Definium Therapeutics seller in Q2 2022 was BlackRock, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2022.